HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

JNJ-26076713

a potent, orally bioavailable, nonpeptide alpha(V) integrin antagonist ; structure in first source
Also Known As:
(3,S,beta,S)-1,2,3,4-tetrahydro-beta-((1-(1-oxo-3-(1,5,6,7-tetrahydro-1,8-naphthyridin-2-yl)propyl)-4-piperidinyl)methyl)-3-quinolinepropanoic acid
Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Bhatwadekar, Ashay D: 1 article (09/2020)
2. Ciulla, Thomas: 1 article (09/2020)
3. Kansara, Viral: 1 article (09/2020)
4. Luo, Qianyi: 1 article (09/2020)
5. Bursell, Sven E: 1 article (03/2008)
6. Clermont, Alan C: 1 article (03/2008)
7. Damiano, Bruce P: 1 article (03/2008)
8. Decorte, Bart L: 1 article (03/2008)
9. Galemmo, Robert A: 1 article (03/2008)
10. Ghosh, Shyamali: 1 article (03/2008)

Related Diseases

1. Choroidal Neovascularization
2. Retinal Neovascularization
3. Retinopathy of Prematurity (Retrolental Fibroplasia)
4. Macular Edema
5. Macular Degeneration (Age-Related Maculopathy)

Related Drugs and Biologics

1. Retinaldehyde (Retinal)
2. Oxygen (Dioxygen)
3. SB-267268
4. Cilengitide

Related Therapies and Procedures

1. Oral Administration